Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

626
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
626
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

423
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
423

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Negation of responsibility: a heavy price to pay?

Journal of the Royal Society of Medicine·2010
Same author

Cutaneous malignant melanoma: audit of the diagnostic process: Assessor's comment.

Annals of the Royal College of Surgeons of England·2009
Same author

Perspectives on the issue of the IJS 6-3.

International journal of surgery (London, England)·2008
Same author

Perspectives on this issue of the IJS 6-2.

International journal of surgery (London, England)·2008
Same author

Not all pain in the left iliac fossa is diverticular disease: A case study of a psoas myxoma and review.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·2006
Same author

Barrett's oesophagus--are British gastroenterologists denying their patients prevention of malignant change?

Journal of the Royal College of Surgeons of Edinburgh·2002

Related Experiment Video

Updated: Jan 7, 2026

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

816

Surgical oncology--40 years behind

R D Rosin

    British Medical Journal (Clinical Research Ed.)
    |December 10, 1983
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
    04:45

    Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way

    Published on: May 10, 2021

    4.3K
    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

    Published on: July 28, 2020

    10.2K

    Related Experiment Videos

    Last Updated: Jan 7, 2026

    Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
    07:50

    Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

    Published on: April 18, 2025

    816
    Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
    04:45

    Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way

    Published on: May 10, 2021

    4.3K
    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

    Published on: July 28, 2020

    10.2K